3M (MMM) stock gained nearly 5% Tuesday and is ... Loss Drug Data Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug.

3M is undergoing a challenging transformation with stagnant revenue, rising debt, and significant legal risks from PFAS litigation, leading to a 32% stock price decline since 2021. Despite a ...

Third Quarter 2024 Results Key Financial Results Revenue: US$33.3m (up 48% ...

3M’s (NYSE:MMM) shares touched a two-year high on Tuesday before falling as much as 3% after reporting quarterly results. U.S. stock indices were little changed, declining less than 1%. The ...

Investigations revealed that a French pharmaceutical company fell victim to a business e-mail impersonation scam by the syndicate in March 2020. The firm transferred more than $10 million for what ...

Oct 22 (Reuters) - 3M Co (MMM.N), opens new tab raised its full-year profit forecast on Tuesday after strong demand for roofing material, industrial adhesives and electronics equipment helped the ...

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order ...

英为财情Investing.com - West Pharmaceutical Services (NYSE: WST)星期四发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益超出了分析师的预期。 在该公司发布的最新财报中，公司每股收益为$1.85，总营收为$746.9M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$709.3M，每股收益为 ...

英为财情Investing.com - Supernus Pharmaceuticals (NASDAQ: SUPN)星期一发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益超出了分析师的预期。 在该公司发布的最新财报中，公司每股收益为$0.69，总营收为$175.69M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$157.3M，每股收益为 ...

Reports Q3 revenue $175.7M, consensus $157.3M. The company said, “For the third quarter and first nine months of 2024, strong performance ...

The group’s Chinese medicine segment primarily drove revenue, which contributed $807.8m. Tianjin Pharmaceutical Da Ren Tang ...